Advertisement

LRRK2 (Leucine-Rich Repeat Kinase 2) Gene on PARK8 Locus in Families with Parkinsonism

  • Zbigniew K. Wszolek
  • Alexander Zimprich
  • Saskia Biskup
  • Ryan J. Uitti
  • Donald B. Calne
  • A. Jon Stoessl
  • Akiko Imamura
  • Matthew J. Farrer
  • Judith Miklossy
  • Thomas Meitinger
  • Thomas Gasser
  • Dennis W. Dickson
  • Patrick L. McGeer
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)

Keywords

Substantia Nigra PARK8 Locus Atypical Parkinsonism LRRK2 Mutation LRRK2 Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Payami H, Zareparsi S. Genetic epidemiology of Parkinson's disease, J Geriatr Psychiatry Neurol 1998;11(2):98–106.PubMedGoogle Scholar
  2. 2.
    Healy DG, Abou-Sleiman PM, and Wood NW, PINK, PANK, or PARK? A clinicians guide to familial parkinsonism. Lancet Neurol 2004;3(11):652–662.PubMedCrossRefGoogle Scholar
  3. 3.
    Funayama M, Hasegawa K, Kowa H, et al. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51(3):296–301.PubMedCrossRefGoogle Scholar
  4. 4.
    Zimprich A, Muller-Myhsok B, Farrer M, et al. The PARK8 locus in autosomal dominant parkinsonism: confirmation of linkage and further delineation of the disease-containing interval. Am J Hum Genet 2003;74(1):11–19.PubMedCrossRefGoogle Scholar
  5. 5.
    Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44(4):601–607.PubMedCrossRefGoogle Scholar
  6. 6.
    Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44(4):595–600.PubMedCrossRefGoogle Scholar
  7. 7.
    Nichols WC, Pankratz N, Hernandez D, et al. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 2005;365:410–412.PubMedGoogle Scholar
  8. 8.
    Di Fonzo A, Rohe CF, Ferreira J, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412–415.PubMedGoogle Scholar
  9. 9.
    Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415–416.PubMedGoogle Scholar
  10. 10.
    Wszolek ZK, Pfeiffer B, Fulgham JR, et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995;45:502–505.PubMedGoogle Scholar
  11. 11.
    Wszolek ZK, Pfeiffer RF, Tsuboi Y, et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004;62:1619–1622.PubMedGoogle Scholar
  12. 12.
    Wszolek ZK, Vieregge P, Uitti RJ, et al. German-Canadian family (family A) with parkinsonism, amyotrophy, and dementia-longitudinal observations. Parkinsonism Relat Disord 1997;3:125–139.CrossRefGoogle Scholar
  13. 13.
    Wszolek ZK, Tsuboi Y, Uitti RJ, et al. PARK8 locus is associated with late-onset autosomal dominant parkinsonism: clinical, pathological and linkage analysis study of family A & D. Neurology 2003;60(suppl 1);282–283.Google Scholar
  14. 14.
    Pal PK, Wszolek ZK, Uitti R, et al. Positron emission tomography of dopamine pathways in familial parkinsonian syndromes. Parkinsonism Relat Disord 2001;8(1):51–56.PubMedCrossRefGoogle Scholar
  15. 15.
    Bosgraaf L, Van Haastert PJ. Roc, a Ras/GTPase domain in complex proteins. Biochim Biophys Acta 2003;1643:5–10.PubMedCrossRefGoogle Scholar
  16. 16.
    Shen J. Protein kinases linked to the pathogenesis of Parkinson's disease. Neuron 2004;44(4):575–577.PubMedCrossRefGoogle Scholar
  17. 17.
    Kachergus J, Mata IF, Hulihan M, et al. Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet 2005;76(4):672–680.PubMedCrossRefGoogle Scholar
  18. 18.
    Hernandez DG, Paisan-Ruiz C, McInerney-Leo A, et al. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2. Ann Neurol 2005;57(3):453–456.PubMedCrossRefGoogle Scholar
  19. 19.
    Lesage S, Ibanez P, Lohmann E, et al. The G2019S LRRK2 mutation in autosomal dominant European and North African Parkinson's disease is frequent and its penetrance is age-dependent. Neurology 2005;64(suppl 1):1826.Google Scholar
  20. 20.
    Paisan-Ruiz C, Saenz A, de Munain AL, et al. Familial Parkinson's disease: clinical and genetic analysis of four Basque families. Ann Neurol 2005;57(3):365–372.PubMedCrossRefGoogle Scholar
  21. 21.
    Perez Tur J. Clinical and molecular findings in LRRK2 Spanish and UK families. Parkinsonism Relat Disord 2005;11(suppl 2):70.Google Scholar
  22. 22.
    Nukada H, Kowa H, Saitoh T, et al. A big family of paralysis agitans. Clin Neurol 1978;18:627–634.Google Scholar
  23. 23.
    Funayama M, Hasegawa K, Ohta E, et al. An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Ann Neurol 2005;57(6):918–921.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Zbigniew K. Wszolek
    • 1
  • Alexander Zimprich
  • Saskia Biskup
  • Ryan J. Uitti
  • Donald B. Calne
  • A. Jon Stoessl
  • Akiko Imamura
  • Matthew J. Farrer
  • Judith Miklossy
  • Thomas Meitinger
  • Thomas Gasser
  • Dennis W. Dickson
  • Patrick L. McGeer
  1. 1.Department of NeurologyMayo Clinic JacksonvilleJacksonvilleUSA

Personalised recommendations